Introduction: Pharmacovigilance systems for herbal drugs focus on monitoring, detecting and preventing adverse effects, interactions and quality-related problems associated with herbal medicines. For B.Pharm students, understanding phytovigilance, spontaneous reporting, signal detection, causality assessment (WHO‑UMC, RUCAM), and regulatory frameworks is essential. Key topics include herb–drug interactions (e.g., St. John’s wort, ginkgo), batch variability, adulteration, contamination, standardization, coding with MedDRA, databases like VigiBase, and risk‑minimization strategies. Practical skills in case documentation, active surveillance (cohort event monitoring) and critical appraisal of herbal safety data prepare students for real‑world pharmacovigilance roles. Now let’s test your knowledge with 30 MCQs on this topic.
Q1. What is the primary definition of pharmacovigilance for herbal drugs?
- Monitoring and evaluating the safety of herbal medicines and related products in real world use
- Testing herbal products only during preclinical animal studies
- Marketing herbal products without safety assessment
- Assessing only efficacy of herbal extracts in clinical trials
Correct Answer: Monitoring and evaluating the safety of herbal medicines and related products in real world use
Q2. What is the main objective of a phytovigilance system?
- To detect, assess and prevent adverse reactions and signals associated with herbal products
- To promote sales of traditional remedies
- To replace all conventional pharmacovigilance activities
- To standardize taste and color of herbal products
Correct Answer: To detect, assess and prevent adverse reactions and signals associated with herbal products
Q3. Which term specifically refers to safety monitoring of herbal medicines?
- Phytovigilance
- Biovigilance
- Toxicovigilance
- Pharmacokinetics
Correct Answer: Phytovigilance
Q4. Which characteristic of herbal drugs complicates pharmacovigilance compared with single‑molecule drugs?
- Multi‑constituent compositions and batch variability
- Identical pharmacokinetics across batches
- Uniform regulatory monographs worldwide
- Single well‑defined active ingredient
Correct Answer: Multi‑constituent compositions and batch variability
Q5. Which spontaneous system is fundamental for collecting herbal adverse event reports worldwide?
- VigiBase (WHO global database)
- MEDLINE literature only
- Manufacturer internal notes only
- Local pharmacy stock records
Correct Answer: VigiBase (WHO global database)
Q6. Which causality assessment method is widely used in herbal pharmacovigilance by regulators and centres?
- WHO‑UMC causality assessment
- Fixed dose reference method
- GMP batch testing algorithm
- Double‑blind placebo causality index
Correct Answer: WHO‑UMC causality assessment
Q7. Which specific scale is designed to assess drug‑induced liver injury and is useful for herbal hepatotoxicity?
- RUCAM (Roussel Uclaf Causality Assessment Method)
- Naranjo algorithm without modification
- Apgar score
- Bradford Hill checklist only
Correct Answer: RUCAM (Roussel Uclaf Causality Assessment Method)
Q8. Which herbal product is most associated with clinically significant interactions leading to reduced efficacy of many drugs?
- St. John’s wort (Hypericum perforatum)
- Aloe vera gel
- Chamomile tea
- Turmeric in culinary doses
Correct Answer: St. John’s wort (Hypericum perforatum)
Q9. Which herbal ingredient is commonly linked to increased bleeding risk when used with anticoagulants?
- Ginkgo biloba
- Licorice root
- Ginseng (low dose)
- Green tea in dietary amounts
Correct Answer: Ginkgo biloba
Q10. What is the principal pharmacokinetic mechanism by which St. John’s wort causes interactions?
- Induction of cytochrome P450 enzymes (e.g., CYP3A4)
- Inhibition of acetylcholinesterase
- Blocking renal tubular secretion only
- Direct antagonism at opioid receptors
Correct Answer: Induction of cytochrome P450 enzymes (e.g., CYP3A4)
Q11. Which international guideline focuses on safety monitoring of herbal medicines?
- WHO guidelines on safety monitoring of herbal medicines
- ICH Q14 analytical guidelines only
- Good Manufacturing Taste Guidelines
- FAO food labeling recommendations only
Correct Answer: WHO guidelines on safety monitoring of herbal medicines
Q12. Which quality issue is a major cause of adverse events for herbal products?
- Adulteration and contamination (heavy metals, undeclared drugs, microbes)
- Excessive labeling compliance
- Overuse of child‑proof caps
- Standardization to a known marker compound
Correct Answer: Adulteration and contamination (heavy metals, undeclared drugs, microbes)
Q13. Which database term system is commonly used to code adverse events in pharmacovigilance including herbals?
- MedDRA (Medical Dictionary for Regulatory Activities)
- ICD‑10 only
- Local trade names without coding
- SNOMED CT without mapping
Correct Answer: MedDRA (Medical Dictionary for Regulatory Activities)
Q14. Which statistical approach is commonly used for signal detection in spontaneous reporting databases?
- Disproportionality analysis (e.g., PRR, ROR)
- Simple arithmetic mean only
- Randomized controlled trial design
- Kaplan‑Meier survival curves for every report
Correct Answer: Disproportionality analysis (e.g., PRR, ROR)
Q15. Which active surveillance method is useful for systematically capturing adverse events after herbal product distribution?
- Cohort event monitoring
- Spontaneous sales monitoring only
- Single case report filing without follow‑up
- Unstructured social media posts only
Correct Answer: Cohort event monitoring
Q16. Which quality control approach helps ensure consistency of an herbal product?
- Standardization to marker compounds and validated assays
- Color matching for visual appeal
- Vague botanical naming on the label
- Using unverified wild‑harvested material only
Correct Answer: Standardization to marker compounds and validated assays
Q17. Which of the following is an example of intentional adulteration of herbal products?
- Addition of synthetic pharmaceuticals (e.g., sibutramine) to weight‑loss herbal supplements
- Proper GMP documentation
- Standardized extraction procedures
- Independent third‑party testing
Correct Answer: Addition of synthetic pharmaceuticals (e.g., sibutramine) to weight‑loss herbal supplements
Q18. Which of the following is NOT typically a challenge in herbal pharmacovigilance?
- Well‑defined single active ingredient in all products
- Under‑reporting of adverse events
- Variability between batches and species misidentification
- Lack of standardized nomenclature and labeling
Correct Answer: Well‑defined single active ingredient in all products
Q19. In pharmacovigilance terminology, what is a ‘signal’?
- Information suggesting a new causal association or new aspect of a known association between an intervention and an event
- A marketing slogan used for herbal brands
- A manufacturing quality control certificate
- An automatic product recall order only
Correct Answer: Information suggesting a new causal association or new aspect of a known association between an intervention and an event
Q20. When is post‑marketing pharmacovigilance most critical for herbal products?
- After widespread market exposure when rare or long‑term effects may emerge
- Only during preclinical testing
- During harvest season only
- Only when a product is recalled
Correct Answer: After widespread market exposure when rare or long‑term effects may emerge
Q21. Which adverse outcome has been notably associated with kava extracts leading to regulatory action in some countries?
- Hepatotoxicity
- Severe photosensitivity only
- Immediate anaphylaxis in all users
- Complete lack of any biological activity
Correct Answer: Hepatotoxicity
Q22. Which limitation applies to the Naranjo causality scale when used for herbal adverse events?
- It was developed for single chemical drugs and may not account for multi‑constituent herbal complexities
- It exclusively addresses herbal adulteration
- It requires genetic testing for every case
- It is the only validated tool for herbal causality
Correct Answer: It was developed for single chemical drugs and may not account for multi‑constituent herbal complexities
Q23. What essential product details should be captured in an herbal adverse event report?
- Exact product name, batch/lot number, dosage, duration and concomitant medications
- Only the patient’s social habits
- Retail price of the product only
- Advertising claims from the manufacturer
Correct Answer: Exact product name, batch/lot number, dosage, duration and concomitant medications
Q24. Which coding or terminology system helps standardize adverse event descriptions across reports?
- MedDRA coding
- Proprietary brand codes only
- Informal layman descriptors without mapping
- Random numeric IDs with no dictionary
Correct Answer: MedDRA coding
Q25. Which risk‑minimization measure is appropriate when a serious herb‑related risk is identified?
- Label warnings, restricted distribution, and healthcare professional education
- Removing all labels from packaging
- Increasing marketing efforts to offset risk news
- Ignoring spontaneous reports
Correct Answer: Label warnings, restricted distribution, and healthcare professional education
Q26. Which data source can complement spontaneous reports for detecting herbal safety issues?
- Electronic health records and cohort studies
- Only commercial sales figures
- Manufacturer promotional materials exclusively
- Unverified social media posts without validation
Correct Answer: Electronic health records and cohort studies
Q27. Which herbal product interaction mechanism commonly reduces plasma concentrations of co‑administered drugs?
- CYP450 enzyme induction leading to increased metabolism
- Inhibition of drug absorption by insoluble fiber only
- Encapsulation preventing release
- Enhancement of renal tubular reabsorption only
Correct Answer: CYP450 enzyme induction leading to increased metabolism
Q28. Which statistical measure is used to identify disproportional reporting of an adverse event with a specific product?
- Proportional Reporting Ratio (PRR)
- Absolute risk reduction in RCTs only
- Mean squared error of formulations
- Logistic manufacturing index
Correct Answer: Proportional Reporting Ratio (PRR)
Q29. What is a polyherbal formulation and why does it complicate causality assessment?
- A product containing multiple herbs, making it difficult to attribute an effect to a single constituent
- A single‑herb extract with defined active compound
- An inorganic mineral supplement only
- An identical batch of a synthetic drug
Correct Answer: A product containing multiple herbs, making it difficult to attribute an effect to a single constituent
Q30. Which activity most improves the quality and frequency of herbal adverse event reporting by pharmacists?
- Targeted training, access to reporting tools and feedback on reports
- Reducing pharmacy staffing and responsibilities
- Prohibiting discussion of herbal safety with patients
- Only selling popular brands without documentation
Correct Answer: Targeted training, access to reporting tools and feedback on reports
